A diode beamstop technology for real time X-ray beam intensity measurement, developed by Diane Bryant and Simon Morton at the Berkeley Center for Structural Biology, was licensed to MiTeGen, which will commercialize a product to enhance X-ray beamlines used for pharma, materials, and biotech research. The Innovation and Partnerships Office managed the licensing process. Read more at IPO.
Scientists working at the Berkeley Center for Structural Biology in the Advanced Light Source (ALS) recently solved the crystallographic structures of several amine transporters in an effort to better understand why the human brain responds to chemicals like dopamine and serotonin. Their findings will help design drugs to treat neurological diseases and may also lead to a better understanding of how drug addiction can be managed. The work was led by HHMI Investigator Eric Gouaux of the Oregon Health & Science University. Read the ALS Science Highlight.